These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1477299)
1. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299 [TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965 [TBL] [Abstract][Full Text] [Related]
3. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8. Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770 [TBL] [Abstract][Full Text] [Related]
4. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica. Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152 [TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845 [TBL] [Abstract][Full Text] [Related]
6. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis. Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627 [TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Srivastava MD; Rossi TM; Lebenthal E Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy. Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516 [TBL] [Abstract][Full Text] [Related]
9. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity. D'Cruz D; Direskeneli H; Khamashta M; Hughes GR J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome. Marcante R; Cavedon G Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953 [TBL] [Abstract][Full Text] [Related]
12. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640 [TBL] [Abstract][Full Text] [Related]
13. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration]. Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781 [TBL] [Abstract][Full Text] [Related]
14. Soluble IL-2-receptor and CD8 in the serum and the periparasitic granuloma of patients with alveolar echinococcosis. Bresson-Hadni S; Monnot-Jacquard B; Racadot E; Lenys D; Miguet JP; Vuitton DA Eur Cytokine Netw; 1991; 2(5):339-44. PubMed ID: 1804323 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Gallo P; Piccinno M; Pagni S; Tavolato B Ann Neurol; 1988 Dec; 24(6):795-7. PubMed ID: 3264690 [TBL] [Abstract][Full Text] [Related]
16. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Adachi K; Kumamoto T; Araki S Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855 [TBL] [Abstract][Full Text] [Related]
17. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus. Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910 [TBL] [Abstract][Full Text] [Related]
18. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868 [TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. Griffin DE; McArthur JC; Cornblath DR J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934 [TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Bodey B; Psenko V; Lipsey AL; Kaiser HE Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]